Mkts

Citius Pharmaceuticals, Inc.

NASDAQ: CTXR
$0.55-0.01 (-2.15%)
As of Nov 6, 9:30 AM ET

Key statistics

Day range
0.530.60
52-week range
0.371.54
Today
Open0.59
Previous close0.55
Volume199.8K
Valuation
Market cap14.96M
P/E ratio—
EPS (TTM)-2.13
Income & risk
Dividend / yield—
Beta1.01
Avg volume277.2K
Discussion

CTXR News

Stories mentioning CTXR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,6673,944
Cost of Goods Sold329.00789.00
Gross Profit1,3383,1550.000.000.000.000.000.00
Operating Expenses
Research & Development1,6341,6001,6411,6213,7672,1272,9152,764
Sales General & Admin
Total Operating Expenses33,53312,1748,4378,78811,26110,04011,05110,634
Operating Income (Loss)(32,195)(9,019)(8,437)(8,788)(11,261)(10,040)(11,051)(10,634)
Interest Income54.0045.0053.0021.0013.0023.00117.00205.00
Interest Expense
Other Expense
Pretax Income(28,341)(9,130)(8,479)(8,940)(11,247)(10,017)(10,934)(10,429)
Tax Provision(231.00)264.00265.00264.00264.00264.00144.00144.00
Net Income (Loss)(11,512)(10,281)(10,573)
Earnings Per Share (Basic)(0.95)(0.38)0.00(0.80)(1.27)(1.30)(1.61)(1.57)
Earnings Per Share (Diluted)(0.95)(0.38)0.00(0.80)(1.27)(1.30)(1.61)(1.57)
Weighted Average Shares Outstanding (Basic)22,37621,49511,06511,0078,5817,4926,7276,954
Weighted Average Shares Outstanding (Diluted)22,37621,49511,06511,0078,5817,4926,7276,954

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CTXR

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTXR. It last traded at $0.5500 (Nov 6, 2026, 9:30 AM ET), down 2.1% on the day. That gives Citius Pharmaceuticals a market capitalisation of $15.0M.

Over the past 52 weeks CTXR has traded between $0.3700 and $1.54.

Revenue for the quarter ended Mar 31, 2026 was $1.7M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026$1.7M—
Dec 31, 2025$3.9M—
Mar 31, 2025—-$11.5M
Dec 31, 2024—-$10.3M

From Citius Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…